This webpage explores valuation and funding data from emerging technology companies to help users understand how investment scale, timing, and industry focus influence company growth.
This page helps you track and interpret private-company valuation using three simple steps: (1) scan high-level performance metrics, (2) read the funding table chronologically, and (3) compare fund marks for institutional perspective. Review sections in that order to build a structured view of valuation dynamics.
Compare "Amount Raised" and "Post-Money Valuation" across rounds to spot growth shifts. Cross-check those rounds with the Mutual Fund Marks to confirm whether institutional valuations align with funding events.
| Funding Date | Share Class | Amount Raised | Issue Price | Post-Money Valuation |
|---|---|---|---|---|
| 2025-12-16 | Series L | 4B | 190 | 134B |
| 2025-09-08 | Series K | 1.12B | 150 | 100B |
| 2024-12-17 | Series J | 10.17B | 92.5 | 62.04B |
| 2023-09-14 | Series I | 684.56M | 73.5 | 43.41B |
| 2021-08-31 | Series H | 1.63B | 73.4841 | 37.89B |
| 2021-02-01 | Series G | 1.03B | 59.1226 | 28B |
| 2019-10-22 | Series F | 408.01M | 14.3161 | 6.2B |
| 2019-02-05 | Series E | 250M | 7.096 | 2.81B |
| 2017-08-22 | Series D | 140M | 2.7941 | 960.3M |
| 2016-12-15 | Series C | 60.37M | 1.966 | 519.62M |
| 2014-06-30 | Series B | 34.14M | 1.1151 | 250.23M |
| 2013-09-25 | Series A | 14M | 0.2595 | 48.68M |
| Reported Date | Fund Name | Fund Ticker | Share Class | Price | Source |
|---|---|---|---|---|---|
| 2025-07-31 | Legg Mason Partners Investment Trust | LCLAX | Series H | 105.8 | See Filing |
| 2025-06-30 | Seasons Series Trust | -- | Series G | 103.51 | See Filing |
| 2025-05-31 | Fidelity Select Portfolios | FSPTX | Series H | 102.8 | See Filing |
| 2025-05-30 | Blackrock Funds | BGSIX | Common | 92.5 | See Filing |
| 2025-04-30 | Legg Mason Partners Investment Trust | LCLAX | Series H | 91.75 | See Filing |
| 2025-03-31 | Blackrock Science And Technology Term Trust | -- | Common | 92.5 | See Filing |
Early funding rounds focus on product development and market validation.Capital raised is relatively small, and valuations reflect higher uncertaintyand limited operational scale.
| Round | Date | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Series A | 2013-09-25 | 14M | 48.68M |
| Series B | 2014-06-30 | 34.14M | 250.23M |
| Series C | 2016-12-15 | 60.37M | 519.62M |
These rounds illustrate how early investors prioritize growth potential over immediate scale, accepting lower valuations in exchange for higher long-term upside.
Late funding rounds signal strong investor confidence and reduced risk. Capital injections increase dramatically, and valuations rise to reflect established market position and revenue scale.
| Round | Date | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Series G | 2021-02-01 | 1.03B | 28B |
| Series J | 2024-12-17 | 10.17B | 62.04B |
| Series L | 2025-12-16 | 4B | 134B |
Compared to early rounds, late-stage funding emphasizes consolidation, market leadership, and long-term stability, with significantly higher valuation benchmarks.